PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24926P0434Medrad centargo dual injector multi-patient — Bayer Healthcare LLC

Bayer Healthcare LLC holds $5.0M across 121 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Nov 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

249-Network Contract Office 9 (36C249)

Awarding office

Bayer Healthcare LLC

Recipient

Nov 30, 2026

PoP end

$134K

Obligated

$134K

Potential

339112

NAICS

6525

PSC

Unrestricted

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted

Contract number36C24926P0434

Also listed as36C249-26-P-0434

Agency249-Network Contract Office 9 (36C249)

Awarding office249-Network Contract Office 9 (36C249)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentBayer Healthcare LLC

CAGE3KEK9

UEIDAVLZMN2HEP5

NAICS339112

No full NAICS 339112 intel page yet. Browse NAICS intelligence

PSC6525

Place of performanceWHIPPANY NJ

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

Related solicitation36C24926Q0263

PoP startSep 15, 2026

PoP end (current)Nov 30, 2026

Obligated$134K

Current value$134K

Potential value$134K

Medrad Centargo Dual Injector Multi-Patient, Dual-Syringe Contrast Media Delivery System is a federal Unrestricted award for 249-Network Contract Office 9 (36C249) held by Bayer Healthcare LLC. Estimated value $134K ($134K obligated). Current period of performance ends Nov 30, 2026. Last award drew 1 bidder. Place of performance: WHIPPANY NJ. Related solicitation 36C24926Q0263.

Medrad centargo dual injector multi-patient, dual-syringe contrast media delivery system

Recompete timing

Public

● Expiring in 43 days

Current PoP ends Nov 30, 2026 (43 days remaining). Agencies typically plan 12–18 months ahead — at 1.4 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 36C24926P0434? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Bayer Healthcare LLC — $5.0M obligated across 121 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($5.0M) · all agencies

Department of Veterans Affairs (VA)$4.3M · 86%Department of Defense (DOD)$465K · 9%Department of Health and Human Services (HHS)$272K · 5%

Open full company profile →

Related awards

Same incumbent

36C26222C0059

BAYER RADIMETRICS EXERCISE OF OPTION YEAR

$153K

Feb 28, 2027

36C25522C0032

EXERCISE OPTION PERIOD 4

$120K

Feb 28, 2027

36C25024P0896

BAYER MEDRAD SYSTEMS SERVICE AGREEMENT

$219K

Mar 31, 2027

36C25924P1075

MEDRAD INJECTOR MAINTENANCE - OY2

$124K

Jul 14, 2027

36C24122P0757

BAYER DIRECTCARE SERVICE AGREEMENT FOR BAYER INJECTORS EXERCISE OPTION YEAR 1

$297K

Aug 28, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24926P0434?

36C24926P0434 (Medrad centargo dual injector multi-patient) is a 249-Network Contract Office 9 (36C249) award with a potential value of $134K, currently held by Bayer Healthcare LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C249-26-P-0434?

36C249-26-P-0434 is the dashed form of PIID 36C24926P0434 (Medrad centargo dual injector multi-patient), held by Bayer Healthcare LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24926P0434?

249-Network Contract Office 9 (36C249) awarded 36C24926P0434 to Bayer Healthcare LLC (potential $134K).

Who is the incumbent on 36C24926P0434?

Bayer Healthcare LLC is the incumbent with $5.0M across 121 related awards in SCOUT’s public footprint. The current period of performance ends Nov 30, 2026.

When does Bayer Healthcare LLC’s 36C24926P0434 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C24926P0434? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Sep 9, 2026